Gephardt has also been significantly involved with the pharmaceutical and healthcare industries. In addition to a large lobbying contract with the Medicines Company, he serves as chair of the Council for American Medical Innovation (CAMI), formed by and affiliated with PhRMA. In this capacity he hired his own firm to lobby for the organization, to push to extend patents and block generic drugs from the market. In 2016, Gephardt also co-founded a Direct primary care group called SolidaritUS Health, with the goal of increasing the accessibility of quality healthcare to working families.